Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,659.89
(
-0.84%
)
US TECH 100
23,984.40
(
-0.61%
)
Dow Jones
46,457.17
(
-1.14%
)
Brent Oil
105.05
(
4.37%
)
Bitcoin
71,534.68
(
-3.25%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: flatlander_60048 post# 128822

Wednesday, 10/19/2011 5:00:43 PM

Wednesday, October 19, 2011 5:00:43 PM

Post# of 257253

What did you make of the $1.5B litigation reserve for improper marketing of Depakote?

ABT’s exposure to Depakote litigation is very old news and most investors probably expected the liability to be close to the amount that has now been reserved, so this is a non-story, IMO.

Depakote has been off-patent for about three years.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now